Pricing Dispute In Pakistan Over Novartis TB Drug Raises Concern Over Supply Shortfall
Reuters: Pricing dispute hits supply of TB drugs in Pakistan
“Swiss pharmaceuticals firm Novartis AG said it has stopped making tuberculosis drugs in Pakistan in a dispute over pricing, prompting fears of a health crisis due to a shortage of drugs in a country with the world’s fifth-highest TB rates…” (Hashim, 7/19).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.